Clopidogrel is a prodrug, one of whose metabolites is an inhibitor of platelet aggregation. Clopidogrel must be metabolised by CYP450 enzymes to produce the active metabolite that inhibits platelet aggregation.
Read about Clopidogrel
This drug has been classified in the anatomical therapeutic chemical (ATC) classification
system as follows: